Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Segmentectomy Versus Lobectomy for Stage IA Lung Adenocarcinoma With Ground-glass Component of Prospective, Randomized, Controlled Clinical Study

NCT05983835 is registered in ClinicalTrials.gov with Fujian Medical University Union Hospital as lead sponsor.

NCT NCT05983835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05983835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Segmentectomy Versus Lobectomy for Stage IA Lung Adenocarcinoma With Ground-glass Component of Prospective, Randomized, Controlled Clinical Study
Lead sponsor
Fujian Medical University Union Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2022
Completion date
October 1, 2025
Enrollment
688 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

combined segmentectomy, ia lung adenocarcinoma